Role of protein citrullination in rheumatoid arthritis
Role of protein citrullination in rheumatoid arthritis
批准号:
10091400
负责人:
Tomas M Mustelin
金额:
$37.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-02-01 至 2024-12-31
关键词:
AddressAffectAllelesAntibodiesApplications GrantsArginineAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmunityBiologicalBiological MarkersBiologyCellsDataDevelopmentDiseaseDrug TargetingEnzymesGeneticHeadHumanIndividualInfectionLinkMalignant NeoplasmsMolecularMonitorNADPH OxidaseNatural ImmunityPRTN3 genePathogenesisPathologicPathway interactionsPatientsPharmaceutical PreparationsPlayPredispositionProtein-arginine deiminaseProteinsPublishingReactionRegulationReportingResearchRespiratory BurstRheumatoid ArthritisRoleSamplingSiteSjogren&aposs SyndromeSpecificitySurfaceSushi DomainSynovial jointSystemic Lupus ErythematosusTestingTherapeuticWorkadaptive immunitybasecitrullinated proteincyclic citrullinated peptidegain of functionin vivoinhibitor/antagonistinsightinterestneutrophilnovelresponsesmall moleculesystemic autoimmune diseasetargeted treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Despite several new treatment options, many patients with rheumatoid arthritis (RA) continue
to suffer from poorly controlled disease. To enable the urgently needed development of better
therapies, the molecular mechanisms that underpin the pathogenesis of RA need to be better
understood. The newest hypothesis postulates that abnormally citrullinated proteins become
`neo'-self-antigens and stoke direct autoimmunity against this modified self. Key questions now
are why and how excessive and/or abnormal citrullination occurs in RA patients.
The research proposed here will provide novel insights into how pathological citrullination
occurs in RA patients. This work will help elucidate the molecular mechanisms by which the
citrullinating enzymes PAD2 and/or PAD4 act in triggering RA. This will, in turn, be invaluable
for evaluating them as drug targets, and will provide biomarker opportunities to monitor the
activity of the disease and possibly stratify RA patients into different subpopulations that may
require different therapies. The Specific Aims are:
AIM 1. The mechanism(s) of increased citrullination in RA patients.
AIM 2. A novel function of PAD4 in oxidative burst regulation.
The first Aim directly seeks evidence in patient samples of the five proposed mechanisms of
pathological citrullination to determine which are operational in vivo. Their contributions
individually, or in combinations, to protein citrullination of disease-relevant substrates,
including substrate mixtures and cells relevant to RA pathogenesis will be investigated.
The second Aim explores the discovery of a novel link between PAD4 and the cytosolic
components of the NADPH oxidase machinery (NOX2) in human neutrophils. The citrullination
of NOX2 components may contribute to the pathogenesis of RA by blocking a protective
oxidative burst response. The molecular details of PAD4 interaction with NOX2 will be
examined and the citrullination of specific arginine residues and the functional consequences of
these sites on the oxidative burst response tested, as this response has been reported to be
involved in tempering autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the L1 retrotransposon in interferon-positive SLE
-
批准号:10603189
-
项目类别:
-
资助金额:$54.75万
-
财政年份:2022
-
负责人:Tomas M Mustelin
-
依托单位:
HERV-K immunity, a trigger of citrullination in rheumatoid arthritis?
-
批准号:10402763
-
项目类别:
-
资助金额:$19.22万
-
财政年份:2021
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:10548134
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:9883195
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:10318576
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
The roots of SLE: Can we cure it with a reverse transcriptase inhibitor?
-
批准号:9922870
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2019
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7725965
-
项目类别:
-
资助金额:$12.13万
-
财政年份:2008
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7622863
-
项目类别:
-
资助金额:$11.62万
-
财政年份:2007
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7380834
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2006
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7167090
-
项目类别:
-
资助金额:$11.24万
-
财政年份:2005
-
负责人:Tomas M Mustelin
-
依托单位:
CORE--Shared Resources Proteomics
-
批准号:6990469
-
项目类别:
-
资助金额:$11.08万
-
财政年份:2004
-
负责人:Tomas M Mustelin
-
依托单位:
Cell Death Induced by Yersinia YopH
-
批准号:6800912
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2004
-
负责人:Tomas M Mustelin
-
依托单位:
PTP-MEG2: Regulation, Substrates, Biology
-
批准号:6844731
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Negative regulation of TCR-associated PTKs
-
批准号:6824908
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:7004490
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6581980
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6839424
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Negative regulation of TCR-associated PTKs
-
批准号:6983414
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
PTP-MEG2: Regulation, Substrates, Biology
-
批准号:7008879
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6694027
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
海外基金